Osaic Holdings’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1
| Closed | – | – | 7692 |
|
|
2024
Q2 | $0 | Sell |
1
-21
| -95% | -$9 | ﹤0.01% | 7697 |
|
|
2024
Q1 | $10 | Hold |
22
| – | – | ﹤0.01% | 7147 |
|
|
2023
Q4 | $16 | Hold |
22
| – | – | ﹤0.01% | 7214 |
|
|
2023
Q3 | $19 | Hold |
22
| – | – | ﹤0.01% | 7323 |
|
|
2023
Q2 | $41 | Sell |
22
-1
| -4% | -$3 | ﹤0.01% | 7339 |
|
|
2023
Q1 | $83 | Hold |
23
| – | – | ﹤0.01% | 7348 |
|
|
2022
Q4 | $0 | Hold |
23
| – | – | ﹤0.01% | 7516 |
|
|
2022
Q3 | $0 | Hold |
23
| – | – | ﹤0.01% | 7590 |
|
|
2022
Q2 | $0 | Hold |
23
| – | – | ﹤0.01% | 7679 |
|
|
2022
Q1 | $1K | Hold |
23
| – | – | ﹤0.01% | 7149 |
|
|
2021
Q4 | $1K | Hold |
23
| – | – | ﹤0.01% | 7284 |
|
|
2021
Q3 | $2K | Hold |
23
| – | – | ﹤0.01% | 6913 |
|
|
2021
Q2 | $2K | Hold |
23
| – | – | ﹤0.01% | 6769 |
|
|
2021
Q1 | $3K | Hold |
23
| – | – | ﹤0.01% | 6425 |
|
|
2020
Q4 | $3K | Hold |
23
| – | – | ﹤0.01% | 6000 |
|
|
2020
Q3 | $3K | Hold |
23
| – | – | ﹤0.01% | 5781 |
|
|
2020
Q2 | $4K | Hold |
23
| – | – | ﹤0.01% | 5599 |
|
|
2020
Q1 | $3K | Buy |
+23
| New | +$3.04K | ﹤0.01% | 5600 |
|
Osaic Holdings's NBSE Position: Q3 2024 in Review
Osaic Holdings sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q3 2024, closing a stake of 1 share.
Osaic Holdings first reported a position in NBSE in Q1 2020 and held it in 18 quarters. The position peaked at $4K in Q2 2020. 1 fund tracked by Wall St. Rank holds NBSE as of Q3 2024.
- Osaic Holdings reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Osaic Holdings sold 1 NeuBase Therapeutics, Inc. Common Stock share in Q3 2024.
- Osaic Holdings first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2020 and held it in 18 quarters.
- Osaic Holdings's NeuBase Therapeutics, Inc. Common Stock position peaked at $4K in Q2 2020.
- 1 fund tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q3 2024.
Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.